Saiph Capital, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2052658 WYCKOFF, NJ

Position in GILD

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$848,625

+$620,198 QoQ

Shares Held

6,717

+309.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.66%

of 13F equity value

Holder Rank

#1,148

of 2,266 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 78% Shared 0% None 22%

Healthcare · as of Jun 30, 2026

Saiph Capital, LLC holds $2,470,546 across 4 Drug Manufacturers - General names. GILD ranks #1 (34.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc. This page	6,717	$848,625
2	LLY	ELI LILLY & Co	536	$642,894
3	MRK	Merck & Co., Inc.	4,425	$568,612
4	JNJ	Johnson & Johnson	1,616	$410,415

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$848,625	6,717	+309.8%	Shares	Sole	2026-07-29
2026-03-31	$228,427	1,639	-1.0%	Shares	Sole	2026-05-12
2025-12-31	$203,134	1,655	-70.4%	Shares	Sole	2026-02-12
2024-12-31	$516,440	5,591	+13.3%	Shares	Sole	2025-02-11
2024-09-30	$413,666	4,934	-1.2%	Shares	Sole	2025-02-11
2024-06-30	$342,775	4,996	+4.8%	Shares	Sole	2025-02-11
2024-03-31	$349,036	4,765	+10.5%	Shares	Sole	2025-02-11
2023-12-31	$349,396	4,313	+38.6%	Shares	Sole	2025-02-11
2023-09-30	$233,138	3,111	-3.2%	Shares	Sole	2025-02-11
2023-06-30	$247,780	3,215	-2.4%	Shares	Sole	2025-02-11
2023-03-31	$273,220	3,293	+5.0%	Shares	Sole	2025-02-11
2022-12-31	$269,139	3,135	—	Shares	Sole	2025-02-11
No filing history on record for this holder in this stock.